Cabaletta Bio (CABA) Change in Account Payables (2018 - 2025)
Cabaletta Bio (CABA) posted quarterly Change in Account Payables of -$1.7 million for Q4 2025, down 163.12% year-over-year from $2.7 million in Q4 2024, and down 259.44% quarter-over-quarter from $1.1 million in Q3 2025.
Cabaletta Bio (CABA) Change in Account Payables (2018 - 2025) Analysis & Trends
Cabaletta Bio's Change in Account Payables history runs 8 years deep, the most recent figure standing at -$1.7 million for Q4 2025.
- In Q4 2025, Change in Account Payables fell 163.12% year-over-year to -$1.7 million; the TTM figure through Dec 2025 stood at $1.5 million (up 53.31% YoY), while the FY2025 annual figure was $1.5 million, up 53.31% from the prior year.
- Change in Account Payables for Q4 2025 stood at -$1.7 million, down from $1.1 million in the prior quarter.
- The five-year high for Change in Account Payables was $2.7 million in Q4 2024, with the low at -$2.0 million in Q3 2024.
- The 5-year median for Change in Account Payables is $580500.0 (2021), against an average of $259150.0.
- Peak annual rise in Change in Account Payables reached 620.36% in 2022, while the deepest fall reached 304.07% in 2022.
- Cabaletta Bio's Change in Account Payables stood at $566000.0 in 2021, then surged by 81.45% to $1.0 million in 2022, then tumbled by 49.56% to $518000.0 in 2023, then soared by 421.81% to $2.7 million in 2024, then slumped by 163.12% to -$1.7 million in 2025.
- Business Quant data shows CABA's Change in Account Payables at -$1.7 million in Q4 2025, $1.1 million in Q3 2025, and $595000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Cabaletta Bio | 466.25 Mn | 466.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.71 Mn |
| Dec 31, 2025 | -1.71 Mn |
| Sep 30, 2025 | 1.07 Mn |
| Sep 30, 2025 | 1.07 Mn |
| Jun 30, 2025 | 595,000.00 |
| Jun 30, 2025 | 595,000.00 |
| Mar 31, 2025 | 1.59 Mn |
| Mar 31, 2025 | 1.59 Mn |
| Dec 31, 2024 | 2.70 Mn |
| Dec 31, 2024 | 2.70 Mn |
| Sep 30, 2024 | -2.01 Mn |
| Sep 30, 2024 | -2.01 Mn |
| Jun 30, 2024 | -1.34 Mn |
| Jun 30, 2024 | -1.34 Mn |
| Mar 31, 2024 | 1.66 Mn |
| Mar 31, 2024 | 1.66 Mn |
| Dec 31, 2023 | 518,000.00 |
| Dec 31, 2023 | 518,000.00 |
| Sep 30, 2023 | 1.30 Mn |
| Sep 30, 2023 | 1.30 Mn |